UNDERWRITING AGREEMENT between HEAT BIOLOGICS, INC. and as Representative of the Several UnderwritersUnderwriting Agreement • January 21st, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • New York
As Representative of the several Underwriters named on Schedule 1 attached hereto 590 Madison Avenue, 36th Floor New York, New York 10022
COMMON STOCK PURCHASE WARRANT HEAT BIOLOGICS, INC.Common Stock Purchase Warrant • January 21st, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations • New York
THIS COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, _____________ or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the date hereof (the “Initial Exercise Date”) and on or prior to 5:00 p.m. New York time on March 22, 2021 (the “Termination Date”) but not thereafter, to subscribe for and purchase from Heat Biologics, Inc., a Delaware corporation (the “Company”), up to ______ shares of common stock, par value $0.0002 per share (the “Common Stock”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
FORM OF INVESTOR AGREEMENTInvestor Agreement • January 21st, 2020 • Heat Biologics, Inc. • Pharmaceutical preparations
This agreement (the “Investor Agreement”) is being delivered to you in connection with an understanding by and between Heat Biologics, Inc., a Delaware corporation (the “Company”), and the person or persons named on the signature pages hereto (collectively, the “Holder”).
